文献速递免疫规划慢病防控与筛查

COVID-19大流行期间肺病儿童的流感疫苗接种

Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic.
PubMed 文献 · Vaccine · 2023-11-17

该研究通过问卷回顾性调查2021年3月至8月就诊于Schneider儿童医学中心儿科肺病研究所的患儿父母,了解其对流感疫苗的认知与接种情况。198名家长中114名(57.3%)为孩子接种流感疫苗。初级医生或肺病专科医生给予解释及推荐与更高的接种率显著相关,家长对疫苗有效性和安全性的认可是接种的促进因素。

要点

  • 198名家长中114名(57.3%)在当年为孩子接种流感疫苗。
  • 初级医生给予解释的家长接种率65.4%,未给予解释的为43.7%(p=0.003)。
  • 肺病专科医生给予解释的家长接种率77.3%,未给予解释的为48.8%(p=0.004)。

核心结论

  • 儿童呼吸系统疾病患者的流感疫苗接种率为57%。
  • 鼓励接种的主要因素是家长正确的知识以及初级医生或肺病专科医生的推荐。
  • 这强调需要通过先向医生解释疫苗重要性来为患者提供信息。

研究设计与样本

  • 研究纳入2021年3月至8月期间携带患儿就诊于Schneider儿童医学中心儿科肺病研究所的家长,通过问卷回顾个人经验和信念,共198名家长完成问卷。

主要发现

  • 198名家长中114名(57.3%)在当年为孩子接种流感疫苗。
  • 患儿平均年龄为6.9±4.5岁。
  • 接种组与未接种组的人口学数据相似。
  • 初级医生给予解释的家长与未给予解释的家长接种率分别为65.4%与43.7%(p=0.003)。
  • 肺病专科医生给予解释的家长与未给予解释的家长接种率分别为77.3%与48.8%(p=0.004)。

临床怎么用

  • 医疗专业人员应建议慢性肺病患儿的家长每年接种流感疫苗作为支持性照护的一部分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Influenza is associated with considerable respiratory morbidity and mortality. Healthcare authorities recommend immunization of all children as vaccinations protect vulnerable populations, minimize influenza triggered asthma attacks, and reduced the burden of respiratory illnesses during the SARS-CoV-2 pandemic. Medical professionals should counsel parents of children with chronic lung disease to receive annual influenza vaccinations as part of supportive care. We aimed to describe adherence to influenza vaccination in respiratory patients and identify potential reasons for non-vaccination. METHODS: This study included questionnaires reviewing personal experience and beliefs regarding influenza vaccination, provided by parents of patients who visited the Pediatric Pulmonary Institute at Schneider Children's Medical Center with their children, during March-August 2021. RESULTS: Of 198 parents who completed our questionnaire, 114 (57.3 %) vaccinated their children against influenza during that year. Average age was 6.9 ± 4.5 years. Demographic data were similar between the vaccinated and unvaccinated groups. Influenza vaccination rates differed significantly between parents who received an explanation from their primary physician and those who did not (65.4 % vs. 43.7 %, respectfully, p = 0.003), and parents who received explanations from a pulmonary specialist and those who did not (77.3 % vs. 48.8 %, respectively, p = 0.004). The combined recommendation of a primary physician and pulmonologist translated to a significantly higher vaccination rate among those who received such recommendations, as compared to those who did not (p < 0.001). Parents who believed in vaccine efficacy and safety were more likely to vaccinate their children (p < 0.001). Factors significantly affecting the decision of the parents to have their child vaccinated were their knowledge, beliefs, and conceptions about the vaccine. CONCLUSIONS: Pediatric respiratory patients' influenza vaccination rate was 57 %. Major factors encouraging vaccination were correct parental knowledge and receiving recommendations from their primary physician\pulmonologist. This emphasizes the need for providing patients with information, by first explaining the vaccine's importance to physicians.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Amitai N, Wertheimer R, Prais D, et al. Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic. Vaccine. 2023. PMID: 37977938. doi:10.1016/j.vaccine.2023.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。